<html>
<head>
  <title>2C19</title>
<style>
  .td {font-family: "verdana"; font-size: "10px"; color: "navy";}
  .green {background-color:"#ACA899";font-family:verdana; font-size:8pt;}
  .lite {background-color:"#F1EFE2";font-family:verdana; font-size:8pt; color:"#666600";}
  A:link {COLOR: "navy"; text-decoration: none;}
  A:visited {COLOR: "navy"; text-decoration: none;}
  A:active {COLOR: "navy"; text-decoration: none;}
  A:hover {COLOR:"#66CCFF";}
</style>
</head>

<body bgcolor="#FFFFFF">
<CENTER>
	<TABLE class="green" border="0" cellPadding="5" cellSpacing="1" width="600">

	
	<tr class="lite"><td>
	<b>References for Cytochrome P450 Drug Interaction Table</b><br>
	Part 3 of 7: 2C19 Isoform<br><br>
	

These pages contain all the literature citations referenced in the Cytochrome P450 Drug Interaction Tables (both the extensive <a HREF="index.htm">research-oriented table</a> and the concise <a HREF="clinlist.htm"> clinical table</a>). Most of these citations are hyperlinks, which bring up the abstract in the NLM's <i>PubMed<sup>®</sup></i> database.
	
<p>
Click on the <font COLOR="Blue"><i><u>PubMed</u></i></font> link after the drug name to perform a live MedLINE search of articles possibly related to that drug and
Cytochrome P450.</p>

<p>
Entries are organized by mode of activity (substrate, inhibitor, inducer)
within specific isoform. You can quickly branch to a section by clicking
on the appropriate link here:
</p>

<center>
  <table ALIGN="Center" cellpadding="5" cellspacing="1" border="0">
    <tr>
      <td class="td"><p ALIGN="Right">1A2:</td>
      <td class="td"><a HREF="1A2.htm#1A2sub">Substrates</a></td>
      <td class="td"><a HREF="1A2.htm#1A2inh">Inhibitors</a></td>
      <td class="td"><a HREF="1A2.htm#1A2ind">Inducers</a></td>
    </tr>
    <tr>
      <td class="td"><p ALIGN="Right">2B6:</td>
      <td class="td"><a HREF="2B6.htm#2B6sub">Substrates</a></td>
      <td class="td"><a HREF="2B6.htm#2B6inh">Inhibitors</a></td>
      <td class="td"><a HREF="2B6.htm#2B6ind">Inducers</a></td>
      </tr>
    <tr>
      <td class="td"><p ALIGN="Right">2C19:</td>
      <td class="td"><a HREF="2C19.htm#2C19sub">Substrates</a></td>
      <td class="td"><a HREF="2C19.htm#2C19inh">Inhibitors</a></td>
      <td class="td"><a HREF="2C19.htm#2C19ind">Inducers</a></td>
    </tr>
    <tr>
      <td class="td"><p ALIGN="Right">2C9:</td>
      <td class="td"><a HREF="2C9.htm#2C9sub">Substrates</a></td>
      <td class="td"><a HREF="2C9.htm#2C9inh">Inhibitors</a></td>
      <td class="td"><a HREF="2C9.htm#2C9ind">Inducers</a></td>
    </tr>
    <tr>
      <td class="td"><p ALIGN="Right">2D6:</td>
      <td class="td"><a HREF="2D6.htm#2D6sub">Substrates</a></td>
      <td class="td"><a HREF="2D6.htm#2D6inh">Inhibitors</a></td>
      <td class="td"><a HREF="2D6.htm#2D6ind">Inducers</a></td>
    </tr>
    <tr>
      <td class="td"><p ALIGN="Right">2E1:</td>
      <td class="td"><a HREF="2E1.htm#2E1sub">Substrates</a></td>
      <td class="td"><a HREF="2E1.htm#2E1inh">Inhibitors</a></td>
      <td class="td"><a HREF="2E1.htm#2E1ind">Inducers</a></td>
    </tr>
    <tr>
      <td class="td"><p ALIGN="Right">3A4,5,7:</td>
      <td class="td"><a HREF="3A457.htm#3A457sub">Substrates</a></td>
      <td class="td"><a HREF="3A457.htm#3A457inh">Inhibitors</a></td>
      <td class="td"><a HREF="3A457.htm#3A457ind">Inducers</a></td>
    </tr>
  </table>
  </center>

<p>
Hint: a quick way to find a specific reference on this page is to use your web browser's Search feature: press Ctrl-F and type all or part of the name or word for which you are searching.</p>
<p>

  <hr>

<a NAME="2C19sub"><img src="2C19substrates.jpg"></a>

<p>
<a name="212c19"><b>2C19 Itself:</b></a>
<i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+CYP2C19&doptcmdl=DocSum">PubMed</a></i>
<p>
<a name="212c19"></a><i>Isolation and Characterization of Human Liver Cytochrome
P450 2C19: correlation between 2C19 and S-mephenytoin
4'-hydroxylation.</i><br>
Wrighton SA, Stevens JC, Becker GW and Vandenbranden M<br>
<a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=8215410&amp;dopt=Abstract">Pubmed
Biochem Biophys 1993 Oct;306(1):240-245</a>
<p>
<a NAME="21amitriptyline"><b>amitriptyline:</b></a>
<i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+amitriptyline&doptcmdl=DocSum">PubMed</a></i>
<p>
<i>Five distinct human cytochromes mediate amitriptyline N-demethylation
in vitro: dominance of CYP 2C19 and 3A4.</i><br>
Venkatakrishnan K, Greenblatt DJ, von Moltke LL, Schmider J, Harmatz JS,
Shader RI<br>
<a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9549641&dopt=Abstract">Clin Pharmacol. 1998 Feb; 38(2): 112-121</a>
<p>
<i>Metabolism of the tricyclic antidepressant amitriptyline by cDNA-expressed
human cytochrome P450 enzymes.</i><br>
Olesen OV, Linnet K<br>
<a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9399333&dopt=Abstract">Pharmacology.
1997 Nov; 55(5): 235-243</a>
<p>
<i>Cytochromes P450 mediating the N-demethylation of amitriptyline.</i><br>
Ghahramani P, Ellis SW, Lennard MS, Ramsay LE, Tucker GT<br>
<a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9131945&dopt=Abstract">Br
J Clin Pharmacol. 1997 Feb; 43(2): 137-144</a>

<p><a name="chloramphenicol"><b>chloramphenicol</b></a>: <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+chloramphenicol+AND+inhibitor&doptcmdl=DocSum"><i>PubMed</i></a></p>
<p><i>Chloramphenicol Is a Potent Inhibitor of Cytochrome P450 Isoforms CYP2C19 and CYP3A4 in Human Liver Microsomes.</i><br>
Park JY, Kim KA, Kim SL.<br>
<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14576103&dopt=Abstract">Antimicrob Agents Chemother. 2003 Nov;47(11):3464-9.</a></p>


<p>
<a name="21citalo"><b>citalopram:</b> </a>
<i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+citalopram&doptcmdl=DocSum">PubMed</a></i>
<p>
<i>Personal communication with Dr. Terence Ketter about citalopram on March
29, 1995.</i><br>
Ketter, T.A<br>
Flockhart, D.A. 1995
<p>
<a NAME="21clomipramine"><b>clomipramine:</b></a>
<i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+clomipramine&doptcmdl=DocSum">PubMed</a></i>
<p>
<i>Pharmacogenetics of antidepressants: clinical aspects.</i><br>
Bertilsson L, Dahl ML, Tybring G<br>
<a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9265947&dopt=Abstract">Acta
Psychiatr Scand Suppl 1997;391:14-21</a>
<p>
<a NAME="21cyclophosphamide"><b>cyclophosphamide:</b></a>
<i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+cyclophosphamide&doptcmdl=DocSum">PubMed</a></i>
<p>
<a NAME="21cyclophosphamide"></a><i>Identification of the polymorphically
expressed CYP2C19 and the wild-type CYP2C9-ILE<sup>359</sup> allele as
low-K<sub>m</sub> catalysts of cyclophosphamide and ifosfamide
activation.</i><br>
Chang TKH, Yu L, Goldstein JA, Waxman DJ<br>
<a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9241661&dopt=Abstract">Pharmacogenetics
1997;7:211-221</a>
<p>
<a name="21diazep"><b>diazepam:</b></a>
<i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+diazepam&doptcmdl=DocSum">PubMed</a></i>
<p>
<a name="21diazep"></a><i>Cytochrome P450 mediated metabolism of diazepam
in human and rat: involvement of human CYP2C in N-demethylation in the substrate
concentration-dependent manner.</i><br>
Yasumori T, Nagata K, Yang SK, Chen L-S, Murayama N, Yamazoe Y, Kato R<br>
<a HREF="http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query">Pharmacogenetics
1993;3:291-301</a>
<p>
<a name="21e-3810"><b>E-3810:</b></a>
<i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+E-3810&doptcmdl=DocSum">PubMed</a></i>
<p>
<a name="21e-3810"></a><i>Comparison of the kinetic disposition and metabolism
of E3810, a new proton pump inhibitor, and omeprazole in relation to
S-mephenytoin 4'-hydroxylation status.</i><br>
Yasuda S, Horai Y, Tomono Y, Nakai H, Yamato C, Manabe K, Kobayashi K, Chiba
K, Ishizaki T<br>
<a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7648764&dopt=Abstract">Clin
Pharmacol Ther 1995 Aug;58(2):143-154 </a>
<p>
<a NAME="21hexobarbital"><b>hexobarbital:</b></a>
<i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+hexobarbital&doptcmdl=DocSum">PubMed</a></i>
<p>
<i>Stereoselective disposition of hexobarbital and its metabolites: relationship
to the S-mephenytoin polymorphism in Caucasian and Chinese subjects.</i><br>
Adedoyin A, Prakash C, O'Shea D, Blair IA, Wilkinson GR<br>
<a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8004130&dopt=Abstract">Pharmacogenetics.
1994 Feb; 4(1): 27-38</a>
<p>
<i>Polymorphism in stereoselective hydroxylations of mephenytoin and hexobarbital
by Japanese liver samples in relation to cytochrome P-450 human-2
(IIC9).</i><br>
Kato R, Yamazoe Y, Yasumori T<br>
<a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=1441599&dopt=Abstract">Xenobiotica.
1992 Sep; 22(9-10): 1083-1092. Review</a>
<p>
<i>Polymorphism in hydroxylation of mephenytoin and hexobarbital stereoisomers
in relation to hepatic P-450 human-2.</i><br>
Yasumori T, Murayama N, Yamazoe Y, Kato R<i><br>
</i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=2311333&dopt=Abstract">Clin
Pharmacol Ther. 1990 Mar; 47(3): 313-322</a>
<p>
<i>Oxidative metabolism of hexobarbital in human liver: relationship to
polymorphic S-mephenytoin 4-hydroxylation.</i><br>
Knodell RG, Dubey RK, Wilkinson GR, Guengerich FP<br>
<a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=3385644&dopt=Abstract">J
Pharmacol Exp Ther. 1988 Jun; 245(3): 845-849</a>
<p>
<a NAME="21imipramine"><b>imipramine N-deME: </b></a>
<i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+imipramine&doptcmdl=DocSum">PubMed</a></i>
<p>
<i>Reappraisal of human CYP isoforms involved in imipramine N-demethylation
and 2-hydroxylation: a study using microsomes obtained from putative extensive
and poor metabolizers of S-mephenytoin and eleven recombinant human
CYPs.</i><br>
Koyama E, Chiba K, Tani M, Ishizaki T<br>
<a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9190854&dopt=Abstract">J
Pharmacol Exp Ther. 1997 Jun; 281(3): 1199-1210.</a>
<p>
<i>Geographical/interracial differences in polymorphic drug oxidation. Current
state of knowledge of cytochromes P450 (CYP) 2D6 and 2C19.</i><br>
Bertilsson L.<br>
<a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8521680&dopt=Abstract">Clin
Pharmacokinet. 1995 Sep; 29(3): 192-209. Review.</a>
<p>
<a name="21indome"><b>indomethacin:</b></a>
<i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+indomethacin&doptcmdl=DocSum">PubMed</a></i>
<p>
<a name="21indome"></a><i>Human cytochrome P4502C metabolism.</i><br>
Weaver RJ, Webster D, Melvin WT, Dickins M and Burke MD<br>
Br J Clin Pharmacol 1993 April;36(2):167P
<p>
<a NAME="21lansoprazole"><b>lansoprazole:</b></a>
<i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+lansoprazole&doptcmdl=DocSum">PubMed</a></i>
<p>
<i>Metabolic disposition of lansoprazole in relation to the S-mephenytoin
4'-hydroxylation phenotype status.</i><br>
Sohn DR, Kwon JT, Kim HK, Ishizaki T<br>
<a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9164419&dopt=Abstract">Clin
Pharmacol Ther 1997 May;61(5):574-582</a>
<p>
<a NAME="21Smephenytoin"><b>S-mephenytoin:</b></a>
<i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+s-mephenytoin&doptcmdl=DocSum">PubMed</a></i>
<p>
<i>Mephenytoin hydroxylation deficiency in Caucasians: frequency of a new
oxidative drug metabolism polymorphism.</i><br>
Wedlund PJ, Aslanian WS, McAllister CB, Wilkinson GR, Branch RA<br>
<a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=6499356&dopt=Abstract">Clin
Pharmacol Ther, 1984 Dec; 36(6):773-780</a>
<p>
<a NAME="21Rmephobarbital"><b>R-mephobarbital:</b></a>
<i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+R-mephobarbital&doptcmdl=DocSum">PubMed</a></i>
<p>
<i>Stereoselective mephobarbital hydroxylation cosegregates with mephenytoin
hydroxylation.</i><br>
Kupfer A, Branch RA<br>
<a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=4042524&dopt=Abstract">Clin
Pharmacol Ther, 1985 Oct; 38(4):414-418</a>
<p>
<a name="21moclob"><b>moclobemide:</b></a>
<i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+moclobemide&doptcmdl=DocSum">PubMed</a></i>
<p>
<a name="21moclob"></a><i>Moclobemide: a substrate of CYP2C19 and an inhibitor
of CYP2C19, CYP2D6 and CYP1A2: A panel study.</i><br>
Gram LF, Guentert TW, Grange S, Vistisen K, Brøsen K<br>
<a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7781267&dopt=Abstract">Clin
Pharmacol Ther 1995;57(6):670-677</a>
<p>
<a NAME="21nelfinavir"><b>nelfinavir:</b></a>
<i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+nelfinavir&doptcmdl=DocSum">PubMed</a></i>
<p>
<i>Characterization of the selectivity and mechanism of human cytochrome
P450 inhibition by the human immunodeficiency virus-protease inhibitor nelfinavir
mesylate.</i><br>
Lillibridge JH, Liang BH, Kerr BM, Webber S, Quart B, Shetty BV, Lee CA<br>
<a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9660842&dopt=Abstract">Drug
Metab Dispos 1998 Jul;26(7):609-16 </a>
<p>
<a NAME="21nilutamide"><b>nilutamide: </b></a>
<i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+nilutamide&doptcmdl=DocSum">PubMed</a></i>
<p>
<i>Nilutamide inhibits mephenytoin 4-hydroxylation in untreated male rats
and in human liver microsomes.</i><br>
Horsmans Y, Lannes D, Larrey D, Tinel M, Letteron P, Loeper J, Pessayre D<br>
<a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=1785203&dopt=Abstract">Xenobiotica
1991 Dec;21(12):1559-1570</a>
<p>
<a name="21omepra"><b>omeprazole:</b> </a>
<i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+omeprazole&doptcmdl=DocSum">PubMed</a></i>
<p>
<i>Effect of omeprazole on diazepam plasma levels in slow versus normal rapid
metabolizers of omeprazole.</i><br>
Andersson T, Cederberg C, Edvardsson G, Heggelund A, Lundborg P<br>
<a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=2104790&dopt=Abstract">Clin
Pharmacol Ther 1990;47(1):79-85</a>
<p>
<a NAME="21pantoprazole"><b>pantoprazole:</b></a>
<i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+pantoprazole&doptcmdl=DocSum">PubMed</a></i>
<p>
<i>Metabolic disposition of pantoprazole, a proton pump inhibitor, in relation
to S-mephenytoin 4'-hydroxylation phenotype and genotype.</i><br>
Tanaka M, Ohkubo T, Otani K, Suzuki A, Kaneko S, Sugawara K, Ryokawa Y, Hakusui
H, Yamamori S, Ishizaki T<br>
<a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9433390&dopt=Abstract">Clin
Pharmacol Ther 1997 Dec;62(6):619-628</a>
<p>
<a name="21phenyt"><b>phenytoin:</b></a>
<i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+phenytoin&doptcmdl=DocSum">PubMed</a></i>
<p>
<i>Role of S-mephenytoin hydroxylase in the metabolism of phenytoin.</i><br>
Bajpai M, Roskos LK, Shen DD, Trager WF, Levy RH<br>
Pharm Res 1994, 11(Suppl):S348
<p>
<b><a NAME="21phenobarb">phenobarbitone:</a></b><font COLOR="#ff00ff"><b><a NAME="21phenobarb">
</a></b></font><font COLOR="Blue"><i><u><a HREF="http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?CMD=Search&amp;DB=PubMed">Pubmed</a></u></i></font>
<p>
<i>CYP2C19 polymorphism effect on phenobarbitone. Pharmacokinetics in Japanese
patients with epilepsy: analysis by population pharmacokinetics.</i><br>
Mamiya K, Hadama A, Yukawa E, Ieiri I, Otsubo K, Ninomiya H, Tashiro N, Higuchi
S<br>
Eur J Clin Pharmacol 2000, 55:821-825
<p>
<b><a NAME="21primidone">primidone:</a></b>
<i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+primidone&doptcmdl=DocSum">PubMed</a></i>
<p>
<a NAME="21progesterone"><b>progesterone:</b></a>
<i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+progesterone&doptcmdl=DocSum">PubMed</a></i>
<p>
<i>Progesterone and testosterone hydroxylation by CYP 2C19, 2C9 and 3A4 in
human liver microsomes.</i><br>
Yamazaki H, Shimada T<br>
<a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9328296&dopt=Abstract">Arch
Biochem Biophys 1997;346(1):161-169</a>
<p>
<a name="21progua"><b>proguanil:</b></a>
<i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+proguanil&doptcmdl=DocSum">PubMed</a></i>
<p>
<i>Metabolic Disposition of proguanil in extensive and poor metabolizers
of S-mephenytoin 4'-hydroxylation recruited from an Indonesian
population.</i><br>
Setiabudy R, Kusaka M, Chiba K, Darmansjah I, Ishizaki T<br>
<a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7619672&dopt=Abstract">Br
J Clin Pharmacol 1995;39(3):297-303</a>
<p>
<i>In vitro proguanil activation to cycloguanil by human liver microsomes
is mediated by CYP3A isoforms as well as S-mephenytoin hydroxylase.</i><br>
Birkett DJ, Rees D, Andersson T, Gonzalex FJ, Miners JO, Veronese ME<br>
<a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8054246&dopt=Abstract">Br
J Clin Pharmacol 1994;37:413-420</a>
<p>
<i>The activation of the biguanide anti-malarial proguanil co-segregates
with the mephenytoin oxidation polymorphism - a panel study.</i><br>
Ward SA, Helsby NA, Skjelbo E, Brøsen K, Gram LF, Breckenridge AM<br>
<a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=1867963&dopt=Abstract">Br
J Clin Pharmacol 1991;31:689-692</a>
<p>
<i>Relation between chloroguanide bioavtivation to cycloguanil and the
genetically determined metabolism of mephenytoin in humans.</i><br>
Funck-Brentano C, Bosco O, Jacqz-Aigrain E, KeunjiN a, Jaillon P<br>
<a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=1587064&dopt=Abstract">Clin
Pharmacol Ther 1992;51(5):507-512</a>
<p>
<a name="21propra"><b>propranolol:</b></a>
<i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+propranolol&doptcmdl=DocSum">PubMed</a></i>
<p>
<a name="21propra"></a><b>Not in vitro.</b> <i>Propranolol oxidation by human
liver microsomes-- use of cumene hydroperoxide to probe isoenzyme specificity
and regio- and stereoselectivity.</i><br>
Otton SV, Gillam EM, Lennard MS, Tucker GT, Woods HF<br>
<a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=2271375&dopt=Abstract">Br
J Clin Pharmacol 1990 Nov;30(5):751-760</a>
<p>
<a name="21r-warf"><b>R-warfarin:</b></a>
<i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+R-warfarin&doptcmdl=DocSum">PubMed</a></i>
<p>
<i>Correlation of human cytochrome P450 2C substrate specificities with primary
structure: warfarin as a probe.</i><br>
Kaminsky LS, de Morais SM, Faletto MB, Dunbar DA, Goldstein JA<br>
<a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8429826&dopt=Abstract">Mol
Pharmacol 1993;43:234-239</a>
<p>
<b><a NAME="21teniposide">teniposide:</a></b>
<i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+teniposide&doptcmdl=DocSum">PubMed</a></i>
<p>
  <hr>

<a NAME="2C19inh"><img src="2C19inhibitors.jpg"></a>

<p>
<b><a NAME="22cimetidine">cimetidine:</a></b>
<i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+cimetidine&doptcmdl=DocSum">PubMed</a></i>
<p>
<a name="22felbam"><b>felbamate:</b></a>
<i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+felbamate&doptcmdl=DocSum">PubMed</a></i>
<p>
<i>Role of S-mephenytoin hydroxylase in the metabolism of phenytoin.</i><br>
Bajpai M, Roskos LK, Shen DD, Trager WF, Levy RH<br>
Pharm Res 1994, 11(Suppl):S348
<p>
<a NAME="22fluoxetine"><b>fluoxetine:</b></a>
<i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+fluoxetine&doptcmdl=DocSum">PubMed</a></i>
<p>
<i>Fluvoxamine and fluoxetine: interaction studies with amitriptyline,
clomipramine and neuroleptics in phenotyped patients.</i><br>
Vandel S, Bertschy G, Baumann P, Bouquet S, Bonin B, Francois T, Sechter
D, Bizouard P<br>
<a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8685072&dopt=Abstract">Pharmacol
Res 1995 Jun;31(6):347-53</a>
<p>
<a NAME="22fluvoxamine"><b>fluvoxamine:</b></a>
<i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+fluvoxamine&doptcmdl=DocSum">PubMed</a></i>
<p>
<i>Fluvoxamine and fluoxetine: interaction studies with amitriptyline,
clomipramine and neuroleptics in phenotyped patients.</i><br>
Vandel S, Bertschy G, Baumann P, Bouquet S, Bonin B, Francois T, Sechter
D, Bizouard P<br>
<a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8685072&dopt=Abstract">Pharmacol
Res 1995 Jun;31(6):347-53</a>
<p>
<b><a NAME="22indomethacin">indomethacin:</a></b>
<i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+indomethacin&doptcmdl=DocSum">PubMed</a></i>
<p>
<b><a NAME="22ketoconazole">ketoconazole:</a></b>
<i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+ketoconazole&doptcmdl=DocSum">PubMed</a></i>
<p>
<a NAME="22lansoprazole"><b>lansoprazole:</b></a>
<i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+lansoprazole&doptcmdl=DocSum">PubMed</a></i>
<p>
<i>Evaluation of omeprazole and lansoprazole as inhibitors of cytochrome
P450 isoforms.</i><br>
Ko JW, Sukhova N, Thacker D, Chen P, Flockhart DA<br>
<a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9224780&dopt=Abstract">Drug
Metab Dispos 1997 Jul;25(7):853-862</a>
<p>
<b><a NAME="22modafi">modafinil:</a></b>
<u><a HREF="http://www.provigil.com/interactions.htm">Info</a></u>
&nbsp;<font COLOR="Blue"><i><u><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+modafinil&doptcmdl=DocSum">PubMed</a></u></i></font>
<p>
<i>In vitro inhibition and induction of human hepatic cytochrome P450 enzymes
by modafinil.</i><br>
Robertson P, DeCory HH, Madan A, Parkinson
A.<br>
<font COLOR="Blue"><u><a HREF="http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=10820139&amp;dopt=Abstract">Drug
Metab Dispos 2000 Jun;28(6):664-71</a></u></font>
<p>
<a NAME="22omeprazole"><b>omeprazole:</b></a>
<i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+omeprazole&doptcmdl=DocSum">PubMed</a></i>
<p>
<i>Evaluation of omeprazole and lansoprazole as inhibitors of cytochrome
P450 isoforms.</i><br>
Ko JW, Sukhova N, Thacker D, Chen P, Flockhart DA<br>
<a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9224780&dopt=Abstract">Drug
Metab Dispos 1997 Jul;25(7):853-862</a>
<p>
<b><a NAME="22paroxetine">paroxetine:</a></b>
<i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+paroxetine&doptcmdl=DocSum">PubMed</a></i>
<p>
<b><a NAME="22probenicid">probenicid:</a></b>
<i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+probenicid&doptcmdl=DocSum">PubMed</a></i>
<p>
<b><a NAME="22ticlopidine">ticlopidine:</a></b>
<i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+ticlopidine&doptcmdl=DocSum">PubMed</a></i>
<p>
<a name="22topira"><b>topiramate:</b></a>
<i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+topiramate&doptcmdl=DocSum">PubMed</a></i>
<p>
<i>Presentation at IBC Conference on Drug-drug interactions.</i><br>
Levy R<br>
December 1996, Washington DC
<p>
  <hr>

<a NAME="2C19ind"><img src="2C19inducers.jpg"></a>

<p>
<b><a NAME="23carbamazepine">carbamazepine:</a></b>
<i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+carbamazepine&doptcmdl=DocSum">PubMed</a></i>
<p>
<b><a NAME="23norethindrone">norethindrone:</a></b>
<i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+norethindrone&doptcmdl=DocSum">PubMed</a></i>
<p>
<a name="23notpent"><b>NOT pentobarbital:</b></a>
<i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+pentobarbital&doptcmdl=DocSum">PubMed</a></i>
<p>
<a name="23notpent"></a><i>Influence of enzyme induction and inhibition on
the oxidation of nifedipine, mephenytoin and antipyrine in humans as assessed
by a &quot;cocktail&quot; study design.</i><br>
Schellens JHM, van der Wart JHF, Brugman M, Breimer DD<br>
<a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=2724144&dopt=Abstract">J
Pharmac Exp Ther 1989;249(2):638-645</a>
<p>
<a name="23predni"><b>prednisone:</b></a>
<i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+prednisone&doptcmdl=DocSum">PubMed</a></i>
<p>
<a name="23predni"></a><i>Influence of corticosteroid on hexobarbital and
tolbutamide disposition</i>.<br>
Breimer DD, Zilly W, Richter E<br>
<a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=679598&dopt=Abstract">Clin
Pharmacol Ther 1978 Aug;24(2):208-212</a>
<p>
<a name="23rifamp"><b>rifampin:</b></a>
<i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+rifampin&doptcmdl=DocSum">PubMed</a></i>
<p>
<a name="23rifamp"></a><i>Induction of polymorphic 4'-hydroxylation of
S-mephenytoin by rifampicin.</i><br>
Zhou HH, Anthony LB, Wood AJJ, Wilkinson GR<br>
<a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=2223426&dopt=Abstract">Br
J Clin Pharmacol 1990;30:471-475</a>
</body></html>
